Specifications table {#sec0001}
====================

Subject area*Organic Chemistry, Spectroscopy, Crystallography, DFT, Molecular docking*Compounds2-(1H-indol-3-yl)-4-phenyl-5,6-dihydrobenzo\[h\]quinoline-3-carbonitrile (Ia)2-(5-bromo-1H-indol-3-yl)-4-(4-methoxyphenyl)-5,6-dihydrobenzo\[h\]quinoline-3-carbonitrile (Ib)Data category*Crystallographic data*Data acquisition format*CIF for crystallography*Data type*Analyzed*Procedure*The title compound was characterized by spectral studies, single crystal X- ray diffraction, Hirshfeld surface, DFT, QTAIM, NCI and molecular docking studies.*Data accessibility**CCDC 1999442 (Ia)** and **CCDC 1999443 (Ib)**[www.ccdc.cam.ac.uk/structures](https://www.ccdc.cam.ac.uk/structures){#interref0001}

1. Rationale {#sec0002}
============

Azaphenantherene ([Fig. 1](#fig0001){ref-type="fig"} ) is a heterocyclic compound containing quinoline moiety. There are many quinoline derived drug candidates are best selling drugs in the market. They are advised for treating various medical conditions. The most promising property of quinoline derivatives is anti-malarial property. *Mefloquine* is a drug used to treat malaria [@bib0001]. *Parasite Vivax, P. malariae, P. falciparum* can be treated by *chloroquine* [@bib0002]. Bisquinoline, ferrocholoroquine and choloroquinolinylthiourea are found to possess good anti-malarial property \[[@bib0003],[@bib0004]\]. Abadi and co-workers have found the analgesic property of fluoromethylquinoline [@bib0005]. The in-vitro and in-vivo studies showed some dihydroquinoline with the inhibition property against farnesyltransferase which can control the cell proliferation in breast cancer cell assay [@bib0006].Fig. 1Medicinal properties of azaphenanthereneFig 1

An epidermal growth factor receptor inhibitor *Pelitinib* and *Pyrotinib* are under clinical trial for lung cancer [@bib0007]. Some hydroxyquinolines [@bib0008] and anilinoquinolines [@bib0009] are screened for their anti-tumor properties.

The derivatives of methoxyquinolines showed anti-bacterial activity against Mycobacterium tuberculosis [@bib0010]. Anti-fungal activities of tetrahydroquinolines were evaluated against *Candida albicans* and it showed good anti-fungal property [@bib0011]. Massari and co-workers synthesized and screened some desfluoroquinolines against its anti-HIV [@bib0012].

Azaphenantherene is a pharmacologically active scaffold having cytotoxic [@bib0013] and anti-inflammatory [@bib0014] properties. Further, this can act as an agonist for serotonin 5HT receptor which is helpful as anti-depressant agent [@bib0015]. Recently, benzo\[h\]quinoline derivatives showed anti-bacterial activity against *Staphylococcus aureus.* Also, some of this kind of derivatives showed anti-cancer property by binding with G-gudruplex biological structures formed in nucleic acids \[[@bib0016],[@bib0017]\].

In this view, this work demonstrates the synthesis, structural and packing analysis of two indole containing azaphenantherene derivatives. The intermolecular hydrogen bonding interactions are qualified and quantified using Hirshfeld surface analysis, QTAIM (Quantum Topological Atoms In Molecules) and NCI (Non-Covalent Interaction) analyses. Also, the molecular docking analysis against main protease (M^pro^) was carried out for the synthesized, modeled compounds and some suggested drugs for COVID-19. The docking results were then analyzed.

2. Materials and methods {#sec0003}
========================

2.1. Synthesis {#sec0004}
--------------

Compounds C~28~H~19~N~3~ (Ia) and C~29~H~20~BrN~3~O.C~2~H~6~OS (Ib) were synthesized using the procedure given below.

### 2.1.1. Preparation of 2-(1H-indol-3-yl)-4-phenyl-5,6-dihydrobenzo\[h\]quinoline-3-carbonitrile (Ia) {#sec0005}

A mixture of 3-(1*H*-indol-3-yl)-3-oxopropanenitrile (0.1 g, 0.543 mM), 4-fluorobenzaldehyde (0.543 mM), ammonium acetate (0.1 g, 1.1 mM) and 3,4-dihydronaphthalen-1(2*H*)-one (0.543 mM) was dissolved in ethanol (10 ml) and heated to reflux on a heating mantle for 2 h. After completion of the reaction as evident from TLC, the reaction mixture was set aside at ambient temperature for 6--7 h. The precipitate formed was filtered and dried to get a pure product. The crystals were obtained from the slow evaporation technique by dissolving the product in DMSO. (Yield: 89%; m.p: 287 -- 288°C). ^1^H NMR (300 MHz, CDCl~3~+DMSO--d~6~) δ~H~: 2.61--2.72 (m, 2H), 2.81 (t, *J*=7.5Hz, 2H), 7.16--7.28 (m, 3H), 7.31--7.42 (m, 4H), 7.43--7.56 (m, 4H), 8.23 (d, *J*=2.4Hz, 1H), 8.46 (d, *J*=7.2Hz, 1H), 8.49--8.57 (m, 1H), 11.42 (bs, 1H) ppm; ^13^C NMR (75 MHz, CDCl~3~+DMSO--d~6~) δ~C~: 23.4, 26.0, 101.6, 110.5, 111.9, 117.4, 119.3, 120.4, 120.9, 124.2, 124.7, 124.9, 125.7, 126.3, 126.5, 127.1, 127.2, 127.4, 128.9, 132.5, 134.6, 135.1, 137.5, 151.7, 153.1, 153.6 ppm; Anal. Calcd. for C~28~H~19~N~3~: C, 84.61; H, 4.82; N, 10.57 %. Found: C, 84.66; H, 4.84; N, 10.54 %. (Fig. S1).

### 2.1.2. Preparation of 2-(5-bromo-1H-indol-3-yl)-4-(4-methoxyphenyl)-5,6-dihydrobenzo\[h\]quinoline-3-carbonitrile (Ib) {#sec0006}

A mixture of 3-(5-bromo-1*H*-indol-3-yl)-3-oxopropanenitrile (0.1 g, 0.543 mM), 4-methoxybenzaldehyde (0.543 mM), ammonium acetate (0.1 g, 1.1 mM) and 3,4-dihydronaphthalen-1(2*H*)-one (0.543 mM) was dissolved in ethanol (10 ml) and heated to reflux on a heating mantle for 2 h. After completion of the reaction as evident from TLC, the reaction mixture was set aside at ambient temperature for 6--7 h. The precipitate formed was filtered and dried to get a pure product. The crystals were obtained from the slow evaporation technique by dissolving the product in DMSO. (Yield: 90%; m.p: 296 -- 297°C). ^1^H NMR (300 MHz, CDCl~3~+DMSO--d~6~) δ~H~: 2.62--2.72 (m, 2H), 2.74--2.85 (m, 2H), 3.81 (s, 3H), 7.0 (d, *J*=8.7Hz, 2H), 7.16--7.25 (m, 3H), 7.29 (d, *J*=8.7Hz, 2H), 7.33--7.43 (m, H), 7.45--7.52 (m, 1H), 8.24 (d, *J*=3.0Hz, 1H), 8.40--8.46 (m, 1H), 8.47--8.54 (m, 1H), 11.53 (bs, 1H) ppm; ^13^C NMR (75 MHz, CDCl~3~+DMSO--d~6~) δ~C~: 23.1, 25.6, 53.3, 101.7, 110.2, 111.6, 112.3, 117.2, 119.0, 120.1, 120.6, 124.2, 124.3, 124.6, 125.4, 126.0, 126.1, 126.2, 128.4, 128.6, 132.2, 134.8, 137.2, 151.3, 152.6, 153.2, 158.0 ppm; Anal. Calcd. for C~29~H~20~BrN~3~O: C, 68.78; H, 3.98; N, 8.30 %. Found: C, 68.80; H, 3.97; N, 8.33 %. (Fig. S1).

2.2. Investigation techniques {#sec0007}
-----------------------------

### 2.2.1. X-ray diffraction data {#sec0008}

The chosen good quality crystal of compound Ia and Ib was mounted on a glass fiber using cyanoacrylate. The fiber was fixed on a goniometer head of Bruker Kappa Apex II diffractometer equipped with CCD area detector using monochromatic X-ray radiation (MoKα, λ=0.71073Å) for collecting the intensity data at room temperature available at Indian Institute of Technology (IIT), Chennai. Accurate unit cell parameters were determined from reflections of 36 frames measured in three different crystallographic zones. The intensity of each reflection is measured by ω/2θ scan mode. The absorption correction (multi-scan) is done with SADABS [@bib0018] program. All the crystal structures were obtained using SHELXS [@bib0019] by direct methods. Full-matrix least-squares refinement procedure was used for solving structures using SHELXL [@bib0019]. All the non-hydrogen atoms were refined anisotropically and hydrogen atoms were positioned from the difference fourier maps and refined isotropically. Hydrogen atoms were positioned in calculated positions, with C-H = 0.93-0.98 Å and N-H = 0.86 Å, and allowed to ride on their respective carrier atoms, U~iso~(H) = 1.2U~eq~(C) for CH~2~, CH and NH groups. Initial structural solution showed co-crystallized completely disordered solvent molecule (DMSO) in compound Ib, which was modeled and refined using PART command along with a free variable. The solvent molecule is disordered over two sets of sites in a 0.792(2):0.208(2) ratio. The final refined structure was validated using PLATON [@bib0020] and CheckCIF routine from IuCr. Thermal ellipsoidal image and molecular packing diagrams were generated using ORTEP [@bib0021] and Mercury [@bib0022]. **CCDC 1999442 (Ia)** and **CCDC 1999443 (Ib)** contains the supplementary crystallographic data. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via [www.ccdc.cam.ac.uk/structures](http://www.ccdc.cam.ac.uk/structures){#interref0002}. The crystallographic data and refinement parameters were listed in [Table 1](#tbl0001){ref-type="table"} .Table 1Crystallographic table of Compounds Ia and IbTable 1Compound - IaCompound - Ib**Empirical formula**C~28~ H~19~ N~3~C~29~ H~20~ Br N~3~ O, C~2~ H~6~O S**Molecular weight**397.46584.52**Temperature (K)**293(2)293(2)**Wavelength (Å)**0.710730.71073**Crystal system**TriclinicTriclinic**Space group**P -1P -1**a (Å)**9.3339(7)10.5600(3)**b (Å)**10.4957(8)11.2058(3)**c (Å)**12.2704(8)12.7280(3)**α** (**°)**82.964(3)°83.158(2)°**β** (**°)**71.834(3)°78.515(2)°**γ** (**°)**64.713(3)°69.156(2)°**Volume (Å^3^)**1032.64(13)1377.47(7)**Z**22**Density (calculated)** (**mg/m^3^)**1.2781.409**Absorption coefficient** (**mm^−1^)**0.0761.601**F(000)**416600**Crystal size (mm^3^)**0.2 × 0.15 × 0.10.2 × 0.15 × 0.1**Theta range for data collection** (**°)**2.521 to 26.5632.322 to 26.728**Index ranges**-11\<=h\<=11,-13\<=k\<=13,-15\<=l\<=15-13\<=h\<=13,-14\<=k\<=14,-16\<=l\<=16**Reflections collected**2012032037**Independent reflections**4201\[R(int) = 0.0390\]5834\[R(int) = 0.0372\]**Completeness to theta = 25.242°**98.6%99.9%**Refinement method**Full-matrix least-squares on F2Full-matrix least-squares on F2**Data / restraints / parameters**4201 / 0 / 2805834 / 0 / 375**Goodness-of-fit on F2**1.0211.002**Final R indices \[I\>2sigma(I)\]**R1 = 0.0538,wR2 = 0.1235R1 = 0.0383,wR2 = 0.0778**R indices (all data)**R1 = 0.1012,wR2 = 0.1465R1 = 0.0826,wR2 = 0.0936**Extinction coefficient**n/an/a**Largest diff. peak and hole (e.Å^−3^)**0.271 and -0.2000.272 and -0.396

### 2.2.2. DFT and intermolecular interaction analysis {#sec0009}

Density functional theory calculations utilizing B3LYP theory with 6-311G(d,p) [@bib0023] as a basis set was performed using ORCA 3.0.3 [@bib0024]. Frontier molecular orbital analysis was done using the optimized structure. The softwares utilized for the intermolecular interaction analysis are CrystalExplorer 3.1 [@bib0025], Multiwfn [@bib0026] and NCIPLOT [@bib0027]. The results are visualized using VMD [@bib0028]. The procedure and principles behind the Hirshfeld surface analysis, QTAIM and NCI can be found somewhere else [@bib0029].

### 2.2.3. Preparation of ligands and its docking {#sec0010}

A ligand database was created containing more than 300 molecules of suggested COVID-19 drugs ([www.drugbank.ca/](http://www.drugbank.ca/){#interref0003}), and some modeled derivatives of azaphenantherene. All the ligand molecules were energy minimized using Steepest descent algorithm employed in Avogadro [@bib0030]. The PDB (Protein Data Bank) file of the macromolecule (6LU7) was retrieved from RCSB protein data bank (<https://www.rcsb.org/>). The active pocket of the protein was predicted using CASTp server ([http://sts.bioe.uic.edu/castp/](http://www.sts.bioe.uic.edu/castp/){#interref0005}). The water molecules were removed, if any, from the protein molecule. A grid box with the size 23.656 × 25.926 × 27.932 with coordinates (x,y,z) of -11.493, 15.366, 69.444 having the grid spacing of 0.375Å was used. The docking Lamarckian Genetic Algorithm (LGA) was allowed to produce 10 docked positions for each ligand. Molecular docking studies were performed using AutoDock vina [@bib0031] in PyRx [@bib0032] software. The final results were analyzed and visualized on the basis of docking scores using Chimera [@bib0033] software.

3. Data, value and validation {#sec0011}
=============================

3.1. Molecular structural features in the single crystals (Ia) and (Ib) {#sec0012}
-----------------------------------------------------------------------

The two compounds differ by the substituent either in fourth position or in the sixth position of the azaphenantherene ring. This substitution does not affect the crystal system. The ORTEP diagrams with thermal ellipsoids at 30% probability with an atom numbering scheme for Ia and Ib are shown in [Fig. 2](#fig0002){ref-type="fig"}, [Fig. 3](#fig0003){ref-type="fig"} .Fig. 2ORTEP diagram of Ia showing 30% probability and atom-numbering schemeFig 2Fig. 3ORTEP diagram of Ib showing 30% probability and atom-numbering schemeFig 3

The bond lengths and angles of azaphenantherene ring are very much similar to the reported structures [@bib0034], [@bib0035], [@bib0036], [@bib0037], [@bib0038], [@bib0039], [@bib0040]. The 14-membered ring (C1-C5/C41-C48/N1) is significantly deviated from planarity (r.m.s deviation of 0.1519(1) Å in (Ia) and 0.2278(2) Å in (Ib) with the fitted atoms). The atoms C41 \[(0.3391(2) Å in (Ia) & -0.4577(2) Å in (Ib)\] and C42 \[(-0.2993(1) Å in (Ia) & 0.3585(2) Å in (Ib)\] have the maximum out of plane deviation. The phenyl ring (C43-C48) ethylenic bridged with cyclohexadiene is nearly a planar, forming an interplanar angle of 11.41(3)° in (Ia) and 20.86(2)° in (Ib). This twist may be due to the saturation at C41 -- C42 and the absence of steric pressure at N1 force the bay angles at C41 and C42 to adopt sp^2^ values. Further, the cyclohexadiene ring adopts screw boat conformation \[Q~2~ = 0.335(1) Å, θ = 63.8(5)° and Q~T~ = 0.374(1) Å\] [@bib0034] in compound (Ia) and distorted screw boat \[Q~2~ = 0.434(2) Å, θ = 68.1(2)° and Q~T~ = 0.467(2) Å\] in compound (Ib) evidenced from the puckering parameters [@bib0041]. The pyridine ring (N1/C1-C5) is a planar with the maximum deviation of 0.0082(2) Å in (Ia) and 0.0061(3) Å in (Ib) with the fitted atoms.

The C2 -- C21 bond length in compounds Ia and Ib are 1.437(3) Å and 1.442(3) Å, which signifies the aromatic type bond length, the bond distance N2 -- C21 is 1.139(2) Å in (Ia) and 1.139(3) Å in (Ib) indicates the triple bond nature [@bib0034]. The angle around C21 \[178.7(2)° in (Ia) and 179.6(3)° in (Ib)\] defines the linearity of the nitrile group. The deviation of C21 and N2 atoms from the mean plane of pyridine \[0.033(3) Å & 0.038(3) Å in (Ia) and 0.053(2) Å & 0.099(4) Å in (Ib)\] defines the coplanarity. These deviations are due to the nearby substitutions in the pyridine ring.

The indole ring (N3/C11-C18) in both the compounds is planar with the r.m.s deviation of 0.0164(2) Å in (Ia) and 0.0146(2) Å in (Ib) with the fitted atoms. The sum of the angles around N3 is 360(2)° in both the compounds, which indicates the sp^2^ hydridization.

The indole ring in both the compounds is in (-) *syn-periplanar* conformation with the pyridine ring evidenced from the torsion N1-C1-C11-C12 \[-20.2(2)° in (Ia) and -20.1(3)° in (Ib)\]. The indole in all the compounds are nearly coplanar with the pyridine which may be seen from the dihedral angle \[22.75(3)° and 20.71(4)° in compounds Ia and Ib respectively\].

The bond lengths and angles of anisole ring are consistent with the similar structure [@bib0042] but the phenyl ring deviates from the normally observable values \[[@bib0034], [@bib0035], [@bib0036], [@bib0037],[@bib0043]\]. From the torsion C2-C3-C31-C32 the phenyl substituent at C3 in the compound Ia \[-95.4(3)°\] is in (-) anti-clinal and anisole in compound Ib \[107.8(3)°\] is in (+) anti-clinal conformation. The substitutions are nearly perpendicular to the pyridine ring \[84.14(3)° in (Ia) and 73.64(3)° in (Ib)\].

The molecular structure of compound Ia is stabilized through an intermolecular interaction N3-H3...N2. ([Table 2](#tbl0002){ref-type="table"} and [Fig. 4](#fig0004){ref-type="fig"} ). The interaction from indole (N3-H3) to cyano nitrogen (N2^i^ \[symmetry code: (i) 2-x, 1-y, 1-z\]) connects the inversely related molecules thus forming an $\left\lbrack {R_{2}^{2}\left( 16 \right)} \right\rbrack$ [@bib0044] lying along the (110) plane. This motif is a characteristic motif of indole and nitrile containing compounds [@bib0045], [@bib0046], [@bib0047], [@bib0048].Table 2Hydrogen bonds for Ia \[Å and °\]Table 2D-H\...Ad(D-H)d(H\...A)d(D\...A)\<(DHA)N(3)-H(3)\...N(2)\#10.862.193.038(3)170[^1][^2]Fig. 4Partial packing diagram of Ia showing $\mathbf{R}_{2}^{2}\left( 16 \right)$ring motifsFig 4

In compound Ib, the host and guest molecules are forming an intermolecular interaction thus stabilizing the crystal. Here the characteristic ring motif was not found because of the strong interaction with the solvent (DMSO) molecule. The atoms N3 and C34 act as donors and O2 in DMSO act as an acceptor ([Table 3](#tbl0003){ref-type="table"} ). The two interactions N3-H3...O2^i^ \[symmetry code: (i) --x, 1-y, 1-z\] and C34-H34...O2^ii^ \[symmetry code: (ii) -x,-y+1,-z+2\] forming a chain motif of $C_{2}^{1}\left( 12 \right)$ ([Fig. 5](#fig0005){ref-type="fig"} ).Table 3Hydrogen bonds for Ib \[Å and °\]Table 3D-H\...Ad(D-H)d(H\...A)d(D\...A)\<(DHA)N(3)-H(3)\...O(2)\#10.861.912.754(3)168C(34)-H(34)...O(2)\#20.932.633.545(4)170[^3][^4]Fig. 5Partial packing diagram of Ib showing $\mathbf{C}_{2}^{1}\left( 12 \right)$chain motifsFig 5

3.2. Hirshfeld surface, QTAIM and NCI analysis {#sec0013}
----------------------------------------------

Hirshfeld surface of compounds Ia and Ib are mapped over d~norm~ surface shown in Fig. S2 and S3 respectively. [Table 4](#tbl0004){ref-type="table"} shows the individual contributions. The colour coded NCI plot along with QTAIM critical points of compounds Ia and Ib are shown in Fig. S4 and S5 and the values of QTAIM descriptors are shown in [Table 5](#tbl0005){ref-type="table"} and [6](#tbl0006){ref-type="table"} .Table 4Contribution of individual interactions to Hirshfeld surfaceTable 4CompoundH -- H(%)C-H/H-C (%)N-H/H-N (%)Br-H/H-Br (%)O-H /H-O (%)C-C (%)C-N /N-C (%)Ia51.926.911.5\--6.63.2Ib42.622.510.19.88.6\--Table 5QTAIM descriptors for IaTable 5Interactionρa.u∇^2^***ρ***a.uG(r)a.uV(r)a.uH(r)a.u$\frac{\left| {\mathbf{V}\left( \mathbf{r} \right)} \right|}{\mathbf{G}\left( \mathbf{r} \right)}$E~bond~ kJ.mol^−1^N3-H3...N2 \#10.01670.05310.0118-0.01040.00150.881-15.396[^5][^6]Table 6QTAIM descriptors for IbTable 6Interactionρa.u∇^2^***ρ***a.uG(r)a.uV(r)a.uH(r)a.u$\frac{\left| {\mathbf{V}\left( \mathbf{r} \right)} \right|}{\mathbf{G}\left( \mathbf{r} \right)}$E~bond~ kJ.mol^−1^N3-H3...O2 \#10.02960.10370.024-0.02270.00160.946-30.791C34-H34...O2 \#20.00780.02220.0054-0.00520.00030.963-7.054[^7][^8]

In both the structures, apparently short contacts seem to influence H-H interaction ([Table 4](#tbl0004){ref-type="table"}). Other significant contributions are from C-H, N-H and O-H interactions. These arise due to the intermolecular interactions present in the compounds. Further contributions are may be due to *van der Waals* interactions.

Hirshfeld surface shows two and four red spots for compounds Ia and Ib respectively (Fig. S2 and S3). In compound Ia, for N--H...N interaction, d~i~ + d~e~ ≈ 2.0 Å which is less than the sum of the *van der Waals* radii 2.74 Å \[[@bib0049],[@bib0050]\] indicated as bright red spots (Fig. S2). These interactions are colour coded as blue in NCI index indicating strong interactions (Fig. S4). The energy of this interaction from QTAIM descriptors is found to be -15.396 kJ/mol ([Table 5](#tbl0005){ref-type="table"}). The 'sign(*λ* ~2~)ρ' values are -0.0167 a.u.

In compound Ib, for N--H...O interaction, d~i~ + d~e~ ≈ 1.7 Å which is less than the sum of the *van der Waals* radii 2.61 Å. The energy of this interaction is -30.791 kJ/mol ([Table 6](#tbl0006){ref-type="table"}) with the 'sign(*λ* ~2~)ρ' value of -0.0278 a.u. and there is an additional C -- H ... O interaction, which is indicated as a light red spot in Hirshfeld surface and in NCI index it is colour coded as green (Fig. S3 and S5). For the C -- H ... O interactions, d~i~ + d~e~ ≈ 1.8 Å which is less than the sum of the *van der Waals* radii 2.61 Å \[[@bib0049],[@bib0050]\]. The energy of this interaction is found as -7.054 kJ/mol, with 'sign(*λ* ~2~)ρ' value of -0.0078 a.u. The green coloured isosurfaces corresponds to H...H *van der Walls* interaction.

From this analysis, it can be concluded that the compound Ib forms a stronger interaction (N3-H3...O2) with the solvent molecule.

3.3. HOMO-LUMO analysis {#sec0014}
-----------------------

The studies on frontier molecular orbital reveal the chemical reactivity, chemical hardness or softness of the molecule and kinetic stability [@bib0051].

It can be seen from [Fig. 6](#fig0006){ref-type="fig"} that the HOMO orbitals are located on both the cyanopyridine and indole moieties while LUMO orbitals are located on azaphenantherene, nitrile group and substituted aryl rings. Therefore the substitution has an influence on the electron accepting ability of the compounds. All the calculated energy parameters along with a log P and dipole moment are given in [Table 7](#tbl0007){ref-type="table"} .Fig. 6Frontier molecular orbitals and energies of the HOMO, LUMOFig 6Table 7Calculated energy values by B3LYP/6-311G(d,p) levelTable 7ParametersCompound - IaCompound - IbE~HOMO~ (eV)-4.503-4.924E~LUMO~ (eV)-2.166-2.462Ionization potential (I) (I = -E~HOMO~) (eV)4.5034.924Electron affinity (A) (A = -E~LUMO~) (eV)2.1662.462Energy gap (ΔE) (eV)2.3372.462Electronegativity (χ) ($\chi = \frac{\left( {I + A} \right)}{2}$) (eV)3.3353.693Chemical potential (µ) ($\mu = - \frac{\left( {I + A} \right)}{2}$) (eV)-3.335-3.693Chemical hardness (η) ($\eta = \frac{\left( {I - A} \right)}{2}$) (eV)1.0831.231Chemical softness (S) ($S = \frac{1}{2\eta}$) (eV)0.4620.406Electrophilicity index (ω) ($\omega = \frac{\mu^{2}}{2\eta}$) (eV)5.1355.54log P3.884.05Dipole moment (debye)1.7472.968

The ionization potential (I) and electron affinity (A) for compound Ia is much lesser than for compound Ib. This makes compound Ia more reactive than compound Ib. This is further confirmed by low chemical hardness (η) and high softness (S) of compound Ia as compared with Ib. Based on the values of electronegativity (χ) and chemical potential (µ), the compound Ia has more electron attracting ability than Ib and this is supplemented by the high electrophilicity index (ω) of Ib. Cell membrane permeability of compound Ib is higher than Ia, this indicates the higher lipophilicity index of compound Ib. The value of the dipole moment, which signifies the ligand-protein interaction on the basis of electrostatic interaction, is much higher in compound Ib than Ia.

Both the compounds are reducers based on the negative HOMO and LUMO values and may undergo oxidative reactions with cytochrome P450 enzyme [@bib0052].

3.4. Molecular docking analysis {#sec0015}
-------------------------------

One of the SARS (Severe Acute Respiratory Syndrome) CoV-2 (Coronavirus-2) enzyme, main protease (M^pro^) or 3-chymotrypsin like protease (3CL^pro^) along with a peptide like N3 inhibitor was first made available on 5^th^ Febrauary 2020 [@bib0053]. This enzyme helps in the viral replication through RNA translation [@bib0054]. This is an ideal target for drug designing in the combat of COVID-19 (Coronavirus disease-2019) since; there is no similar enzyme in human [@bib0053]. Generally protease inhibiting drugs targeting the hydrophobic pockets [@bib0055]. The catalytic residues of this enzyme are formed by a dyad His41-Cys145 which is in the hydrophobic region of the active pocket [@bib0056].

All the ligand molecules were docked in the active site and results are given as [Fig. 7](#fig0007){ref-type="fig"} , [Table 8](#tbl0008){ref-type="table"} , S1 and S2. The peptide like inhibitor N3formed interactions with the amino acids, His 41, Phe 140, Asn 142, His 163, His 164, Glu 166, Gln 189 and Thr 190 [@bib0057]. Both the synthesized compounds (Ia and Ib) show the similar kind of behavior in the active pocket of possessing same hydrogen bonding interactions ([Fig. 7](#fig0007){ref-type="fig"}). The difference in the conformations of pyridine in Ia and Ib plays a role. This difference clearly alters the hydrogen bond distance, which is reflected in the binding energy. Clearly, the screw boat conformation (Ia) forms relatively stronger interaction with high binding energy (-9.4 kcal/mol) than the distorted (Ib) conformation (-8.7 kcal/mol) ([Table 8](#tbl0008){ref-type="table"}). Both the compounds filled the active pocket and resides exactly above the catalytic residues, thus blocks the substrate binding (Fig. S6).Fig. 7The interactions between the synthesized compounds Ia (left) and Ib (right) with the amino acids of SARS CoV-2 main proteaseFig 7Table 8Azaphenantherene derivatives with binding energy and Lipinski\'s rule of 5 criteriaTable 8CompoundM. wt(g/mol)No. of H-bond donorsNo. ofH-bond acceptorslog PHydrogen bond (docking)Distance (Å)B.E (kcal/mol)Lipinski\'s rule violations8397.47123.88ASN 142SER 144GLU 1662.682.882.11**-9.4**09506.39134.05ASN 142SER 144GLU 1662.82.922.11-8.71

Among the virtually screened drugs, Lopinavir showed the maximum binding energy (-10.1 kcal/mol) with two interactions (Gly 143, Glu 166). Ribavirin bounds tightly inside the active pocket through seven interactions with six amino acids (Table S1). Among the six residues four residues are same as that of N3. Favipiravir (-5.0), Galidesivir (-7.2), Hydroxychloroquine (-6.4), Remesesvir (-8.5), Umifenovir (-7.1) formed minimum two interactions.

The modeled compounds were interacted in the similar fashion as that of the synthesized compounds. The compound M-2 having the highest binding energy (-9.0 kcal/mol; 2 interactions) and M-4 having the highest interactions (-8.2 kcal/mol; 6 interactions) (Table. S2).

4. Conclusion {#sec0016}
=============

In this work, two azaphenantherene derivatives differ by the substituent either in fourth position or in the sixth position were synthesized. Their structures were elucidated using SXRD. The substitution does not affect the crystal system, but changes the physicochemical properties. From the intermolecular interaction analyses, the compound Ib was found to have very strong interaction of -30.791 kJ/mol with the solvent DMSO molecule. Based on the electronegativity, electrophilicity index and dipole moment, it is concluded that compound Ib showed better drug-like properties than Ia. Docking analysis suggests that, the drugs Lopinavir and Ribavirin can be used as an inhibitor of SARS CoV-2 main protease. Also, the synthesized compounds Ia, Ib and modeled compounds M-2 and M-4 were found to be occupied the active pocket and interact with the amino acids confirmed their efficacy of inhibiting M^pro^. However, further *in-vitro* and *in-vivo* analyses around these mentioned compounds are required to ascertain these suggestions.
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[^1]: Symmetry transformations used to generate equivalent atoms:

[^2]: \#1 2-x, 1-y, 1-z

[^3]: Symmetry transformations used to generate equivalent atoms:

[^4]: \#1 --x, 1-y, 1-z \#2 -x,-y+1,-z+2

[^5]: Symmetry transformations used to generate equivalent atoms:

[^6]: \#1 2-x, 1-y, 1-z

[^7]: Symmetry transformations used to generate equivalent atoms:

[^8]: \#1 --x, 1-y, 1-z \#2 -x,-y+1,-z+2
